Ricin is a highly toxic compound derived from the castor bean plant, Ricinus communis. It is one of the deadliest poisons known to man, and has been used as a weapon of terror in the past. Ricin is a simple and inexpensive toxin to produce, making it a potential threat to public health and safety. In this article, we will explore the deadly potential of ricin, including its history, structure, and clinical effects.
Ricin has been known since antiquity, and was first described by the Greek physician Dioscorides in the first century AD. It was later used as a poison by the Byzantine Empire, and was reportedly used by the British during World War II. Ricin is also known to have been used as a weapon of terror in the past, including the assassination of Georgi Markov in 1978.
Ricin is a glycoprotein composed of two subunits, the A chain and the B chain. The A chain is responsible for the toxic effects of ricin, while the B chain is responsible for binding the toxin to cell membranes. Ricin can be produced from the castor bean plant, which is widely available and easy to grow. Ricin can also be extracted from the waste material produced during the processing of castor oil.
Ricin poisoning is a serious medical condition that can result in death if not treated promptly. Symptoms of ricin poisoning include nausea, vomiting, diarrhea, abdominal pain, and difficulty breathing. Severe cases can lead to multiple organ failure and death. Treatment of ricin poisoning is largely supportive, with the goal of preventing further absorption of the toxin and treating any complications that may arise.
Ricin is a highly toxic compound that has been used as a weapon of terror in the past. It is easy to produce and can be deadly if not treated promptly. Doctors should be aware of the deadly potential of ricin and be prepared to recognize and treat any cases of ricin poisoning that may arise.
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation